[Clinical experience with 17-beta-hydroxy-17-alpha-methyl-2-oxa-5-alpha-androstan-3-one (oxandrolone)].

Harada, H; Osawa, K; Otsuka, S; Wada, S; Kiuchi, R

Harada, H; Osawa, K; Otsuka, S; Wada, S; Kiuchi, R.

Horumon To Rinsho ; 17(3): 207-12, 1969 Mar.

Article in Ja | MEDLINE | ID: mdl-5815499

Subject(s)

Anorexia Nervosa/drug therapy; Cerebral Hemorrhage/drug therapy; Intracranial Embolism and Thrombosis/drug therapy; Oxandrolone/therapeutic use; Stomach Diseases/drug therapy; Tuberculosis, Pulmonary/drug therapy; Adolescent; Adult; Body Weight/drug effects; Female; Humans; Male; Oxandrolone/adverse effects; Tablets

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxandrolone / Stomach Diseases / Tuberculosis, Pulmonary / Anorexia Nervosa / Intracranial Embolism and Thrombosis / Cerebral Hemorrhage Limits: Adolescent / Adult / Female / Humans / Male Language: Ja Journal: Horumon To Rinsho Year: 1969 Document type: Article Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links